Form D · Biotechnology
PharmaTher Holdings Ltd.
Toronto, A6 · CIK 0001886748
Offering snapshot reported Oct 8, 2021 · SEC filing
- Reported sold
- $7.89M Offering amount: $17.7M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 28, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 8, 2021 | Initial | $7,886,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $631K (estimated)
- Form D file number
- 021-416365
Total Offering Amount equals the price of units (15,625,000 units @ C$0.64), plus the aggregate exercise price of warrants forming part of the units (15,625,000 warrants @ C$0.80), converted to US$.
Finder's Fees represents cash fee of C$800,000, converted to US$, were paid to H.C. Wainwright & Co. LLC ("HCW"). HCW also received 1,250,000 agent warrants each exercisable into a common share of the Issuer at C$0.80 per share of the Issuer for 5 years.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| H.C. Wainwright & Co., LLC | 375 |
Source: Form D, filed Oct 8, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Fabio Chianelli | Director, Executive |
| Beverly James Incledon | Director |
| Carmelo Marrelli | Executive |
| Andrew Newbury | Executive |
| Carlo Sansalone | Director |
| Christian Scovenna | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
82 Richmond Street East
Toronto, A6, M5C 1P1
Toronto, A6, M5C 1P1